Choice - Best Stock Broker in India
  • About
  • App
  • Services
    Services
  • Research
  • Partners
  • Contact
  • Log In
  • Open Demat Account
  • Home
  • Blog
  • ...
  • Aster DM Healthcare Plans To Expand Bengaluru Hospital, Shares Up 2%
  • ...
    Aster DM Healthcare Plans To Expand Bengaluru Hospital, Shares Up 2%

Aster DM Healthcare Plans To Expand Bengaluru Hospital, Shares Up 2%

Aster DM Healthcare Plans To Expand Bengaluru Hospital, Shares Up 2%
  • Published Date: May 27, 2024
  • Updated Date: May 27, 2024
  • By Team Choice
Aster CMI Hospital will expand by 300,000 sq. ft., increasing bed capacity to 850 and aims to add 1,700 beds across India by FY27.

Shares of Aster DM Healthcare traded 2% higher after the company announced on Monday morning to expand Aster CMI Hospital in Bengaluru. The shares were trading at 374.55 apiece on NSE at 11.05 am.

An expansion plan for the Aster CMI Hospital in Bengaluru has been revealed by integrated healthcare provider Aster DM Healthcare. The hospital will be able to accommodate 850 beds after the extension, adding 300,000 square feet to its existing infrastructure. With this expansion, the hospital will have 1,602 beds overall in the city, making it one of the biggest healthcare facilities in the region.

Upgrading the current facility will cost the company about ₹250 crore, and the enhanced infrastructure should be implemented by FY2027. Located in Hebbal, Bangalore, the 4.45 million sq. ft. Aster CMI Hospital is well known for its state-of-the-art facilities, offering a wide range of services from primary care to acute care Since its inception in 2016, it became one of India's leading specialist hospitals

The company plans to add over 1,700 beds by FY27, increasing its total number of beds in India to approximately 6,600 through organic growth. On the other hand, Aster is also looking into inorganic development opportunities to keep its place among the top three integrated healthcare providers in the country. In this development plan, brownfield and greenfield projects—like the proposed Aster Capital in Trivandrum and Aster MIMS Kasargod—are combined with the construction of additional beds at existing hospitals.

“We are running our existing clinic [Aster CMI] at full capacity, so we have decided to expand the program to meet the growing needs of patients,” said Dr Nitish Shetty, Aster DM Healthcare CEO, India, responded by mentioning the expansion. He stated that with this expansion, Aster CMI-Hospital continues to live up to its reputation of providing exceptional care to the people around it Aster CMI Hospital expansion will improve PAT and EBITDA as it costs less than fixed costs to make a new bed. So the hospital brand doesn’t expect any short-term margin erosion.

Recommended for you

loading

Copper Price Forecast for Next Week

loading

Indian Stock Market Prediction For Next Week

loading

38 Candlestick Patterns Every Trader Should Know

loading

FII DII Data - Live Data

Official Choice India Logo
  • Services

  • Stocks
  • Mutual Funds
  • Wealth Planning
  • Insurance
  • Loans
  • Capital Advisory
  • Management Consultancy
  • Government Advisory
  • Institution
  • Company

  • Our Team
  • Investors
  • Calculator
  • Careers
  • Contact Us
  • Refer & Earn
  • FAQ’s
  • Resources

  • Fundamental
  • Technical
  • Blog
  • Pricing
  • Downloads
  • News & Media
  • Offer Document
  • Track Record
  • Investor Charter
  • Investor Grievances
  • Online KYC Updation
  • Quick Links

  • Open Demat Account
  • Corporate Demat Account
  • NRI Demat Account
  • Minor Demat Account
  • Market Prediction
  • Lowest Brokerage
  • Investor Charter
  • Investor Awareness
  • Watchout Investors
  • Investor's Advisory
  • Disclaimer
  • CEBPL Policies & Disclosures
  • CFPL Policies & Disclosures
  • Sachet Portal
  • Direct Pay-in

Choice International Limited , Sunil Patodia Tower,
J B Nagar, Andheri(East),
Mumbai 400099.

Monday - Friday : 08:30 am - 7:00 pm
Saturday : 10:00 am - 4:00 pm

+91-88-2424-2424

care@choiceindia.com

Certification Badge - Choice India Is A Great Place To Work
Google Play
App Store Choice India App On Ios DevicesApp Store
  • Made with in India
  • Privacy Policy
  • Terms & Conditions

Choiceinternational. CIN - L67190MH1993PLC071117
Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ).
Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015 , DP ID CDSL - 12066900 , NSDL ID - IN301895. Research Analyst - INH000000222
Choice Wealth Private Limited: AMFI - Registered Mutual Fund Distributor. Association of Mutual Funds in India Registration Number - ARN - 78908.
Initial Registration: 15th March 2010 Valid Till: 14th March 2027.
Pension Fund Regulatory and Development Authority (PFRDA) - POPSE52022022 | Affiliated with POP HDFC Pension Management Company.
Choice Finserv Private Limited: NBFC Registration Number : N - 13.02216

Choice Insurance Broking Private Limited: IRDAI License No: 167, License Valid Till: 29-05-2025 | Category : Direct ( Life & General )
Registered Office: Choice International Limited, Sunil Patodia Tower, J B Nagar, Andheri East, Mumbai, Maharashtra 400099.
For any Grievances / Queries email at ig@choiceindia.com & care@choiceindia.com | Online Dispute Resolution Link: https://smartodr.in/login

Cautionary Message :

  1. Sharing of trading credentials – login id & passwords including OTP’s:- Keep Your Password/Pin and OTP’s private & confidential to avoid any misuse or unauthorised trades. Please ensure that you do not share it with any one.
  2. Trading in leveraged products like options without proper understanding, which could lead to losses
  3. Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
  4. Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  5. Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers

Disclaimer:
1. *Investments in securities market are subject to market risks, read all the related documents carefully before investing.
2. In addition to client based business, we are also doing proprietary trading.
3. Brokerage will not exceed the SEBI prescribed limit.

Research Disclaimer and Disclosure inter-alia as required under Securities and Exchange Board of India (Research Analysts) Regulations, 2014

Choice Equity Broking Private Limited (“CEBPL”) is a registered Research Analyst Entity (Reg. No. INH000000222 ) (hereinafter be referred as “CEBPL”). (CIN. NO.: U65999MH2010PTC198714).

Reg. Address: Sunil Patodia Tower, J B Nagar, Andheri(East), Mumbai 400099. Tel. No. 022-6707 9999 .

Compliance Officer: Mr.Prashant Salian. Tel. 022-67079999 - Ext-2310
Email- Prashant.salian@choiceindia.com

Grievance officer: Deepika Singhvi Tel.022-67079999- Ext-834.
Email- ig@choiceindia.com

Research Disclaimer: Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© Choice International Limited. All Rights Reserved.